121 East 60th Street, Suite 8AB New York, NY 10022

Ph. (212) 285-1110

Long Island

901 Stewart Ave, Suite 240 Long Island, NY 11530

Ph. (516) 512-7616

Xeomin Press Release

Xeomin Is the Latest Competitor Against Wrinkles: Is It the New Botox?

Fine facial lines and wrinkles are the first signs of aging. Botox has been the gold standard for over a decade, but a new cosmetic wrinkle treatment is showing great promise as a fast acting injected medication with ingredients that have been attracting younger patients and New York City Dermatologist, Dr. Cameron Rokhsar, M.D., is calling “The new kid on the block.”

Xeomin is an effective tool to improve the look of mild, moderate and severe frown lines.

Garden City, New York (PRWEB) January 19, 2013

Xeomin has been recently released, making it the newest treatment available for erasing wrinkles and smoothing skin much like its predecessor, Botox. Xeomin and Botox share the identical active ingredient, botulinum toxin A. Botulinum toxin is a naturally occurring purified neurotoxin used to treat muscle spasms, abnormal neck pain, and its most popular use, wrinkles. This neurotoxin enables both Xeomin and Botox to function successfully by paralyzing facial muscles and smoothing out wrinkles. The only difference is that Xeomin does not have any of the additives that Botox contains. Botulinum that is free from complexing proteins is called incobotulinum, giving it the theoretical advantage to decrease the likelihood of a patient developing resistance to treatment. When the body senses a foreign substance, it responds by creating antibodies to attack, but because Xeomin only contains incobotulinum toxin type A, the possibility of an adverse reaction is reduced.

Cosmetic anti-wrinkle injections have recently attracted younger users as a preventative solution. Just as Xeomin has become the youngest botulinum injection available, its anti-wrinkle properties have increased in popularity among younger patients. The trend is gaining momentum as more and more cosmetic dermatologists are seeing younger patients requesting injections of botulinum before wrinkles even develop. Xeomin is a viable competitor against Botox and Dysport, another botulinum based neurotoxin, for eliminating wrinkles and creating natural and effective improvements to the face.

This un-complex version of Botox relies solely on the botulinum toxin to act on the neural pathways that coordinate muscle movements. Botox contains chaperone proteins, which cause it to take effect about five days after injection while Xeomin works as early as three days after the five to ten minute treatment. Diffusion studies have shown that even though Xeomin does not contain Botox’s proteins, it acts just as effectively at staying in the intended injection site.

When the brain is directed to laugh or frown, it sends a signal that travels through a nerve to reach the muscle tissue and trigger a physical corresponding action. Xeomin cuts that line of communication, ultimately preventing the signal from reaching the muscle. When the muscle cannot be triggered to contract, it remains in a relaxed state, which not only addresses wrinkles that have already formed, but also prevents creases from forming in the first place. Patients will stop overusing the muscles that cause repeated facial micro-movements that form undesirable lines along the face overtime; telltale signs of aging. This does not prevent you from making facial expressions, but simply stops your face from making muscle contractions deep within the skin that ultimately cause harder to treat wrinkles.

Dr. Rokhsar is fellowship-trained cosmetic surgeon and an expert in treating patients with Botox, Dysport and Xeomin. He was selected along with a specialized group of physicians to have early access to Dysport and Xeomin in order to test their efficacy, providing Dr. Rokhsar with an exclusive expertise and knowledgeable precision.

“Xeomin is an effective tool to improve the look of mild, moderate and severe frown lines,” Dr. Rokhsar says. “Because it’s a purer form of Botox, it may have the advantage to work faster.”

Like Botox, Xeomin provides the same benefits and effectiveness in diminishing glabellar wrinkles. Other wrinkles that Xeomin and Botox treat with equal success rates are crow’s feet or fine lines around the eyes, upper lip lines, and horizontal forehead creases. Botulinum injections not only have cosmetic benefits, but can address medical conditions such as alleviating TMJ pain, the condition caused by the inflammation of your temporomandibular joint and can also relax platysma muscles, which are the bands located under the chin and down the neck that are notorious for protruding with age.

This cosmetic injection can help so many reverse the notorious signs of aging such as wrinkles formed between the eyebrows, on the forehead, around the eyes and mouth as a result of frowning, scowling, squinting from the sun, or merely concentrating on a task such as listening or reading. Similar to Botox, the results tend to last three to four months and fade away gradually. Xeomin has thrived on the global market since 2005 and with its recent introduction to the U.S. market, this new wrinkle reducer will provide patients with an impressive and formidable cosmetic medication.

Dr. Cameron K. Rokhsar, M.D., was given early access to Xeomin two year prior to its release, providing him with an unrivaled expertise on the product’s uses. As the leading authority in laser surgery and non-invasive techniques, Dr. Rokhsar, has extensive training and expertise in the field of skin tightening and wrinkle reduction. A graduate of Harvard and New York University, Dr. Rokhsar is a fellowship-trained dermatologist and laser surgeon and extensively published medical author and Professor of Dermatology at Albert Einstein College of Medicine. His offices are located in New York City and Garden City, Long Island.

For more information please contact: Samantha Olson (516) 512-7616